Evidence map›Paper›PMID 35601611›Full record

ArticleFrontiers in aging neuroscience2022

A Tensorized Multitask Deep Learning Network for Progression Prediction of Alzheimer's Disease.

Solale Tabarestani, Mohammad Eslami, Mercedes Cabrerizo, Rosie E Curiel, Armando Barreto, Naphtali Rishe, David Vaillancourt, Steven T DeKosky, David A Loewenstein, Ranjan Duara and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Solale TabarestaniCenter for Advanced Technology and Education, Florida International University, Miami, FL, United States.
Mohammad EslamiHarvard Ophthalmology AI Lab and Harvard Medical School, Schepens Eye Research Institute, Massachusetts Eye and Ear, Boston, MA, United States.
Mercedes CabrerizoCenter for Advanced Technology and Education, Florida International University, Miami, FL, United States.
Rosie E CurielCenter for Cognitive Neuroscience and Aging, Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Miami, FL, United States.
Armando BarretoCenter for Advanced Technology and Education, Florida International University, Miami, FL, United States.
Naphtali RisheCenter for Advanced Technology and Education, Florida International University, Miami, FL, United States.
David VaillancourtFlorida Alzheimer's Disease Research Center, University of Florida, Gainesville, FL, United States.
Steven T DeKoskyFlorida Alzheimer's Disease Research Center, University of Florida, Gainesville, FL, United States.
David A LoewensteinCenter for Cognitive Neuroscience and Aging, Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Miami, FL, United States.
Ranjan DuaraFlorida Alzheimer's Disease Research Center, University of Florida, Gainesville, FL, United States.
Malek AdjouadiCenter for Advanced Technology and Education, Florida International University, Miami, FL, United States.
University of Florida · USFlorida International University · USSmith-Kettlewell Eye Research Institute · USUniversity of Miami · US

Funding

Social Determinants of Health, Race/Ethnicity, and White Matter HyperintensitiesP30AG066506 · NIA · UNIVERSITY OF FLORIDA · PI Ranjan Duara, DAVID LOEWENSTEIN · 2020 to 2026
$25.6M
Precision-based Assessment for the Detection of Mild Cognitive Impairment in Older AdultsR01AG055638 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CURIEL CID, ROSIE E · 2018 to 2022
$2.9M
NIA NIH HHS L30 AG060558NIA NIH HHS P30 AG066506NIA NIH HHS R01 AG055638
6 · The paper itself

Abstract

With the advances in machine learning for the diagnosis of Alzheimer's disease (AD), most studies have focused on either identifying the subject's status through classification algorithms or on predicting their cognitive scores through regression methods, neglecting the potential association between these two tasks. Motivated by the need to enhance the prospects for early diagnosis along with the ability to predict future disease states, this study proposes a deep neural network based on modality fusion, kernelization, and tensorization that perform multiclass classification and longitudinal regression simultaneously within a unified multitask framework. This relationship between multiclass classification and longitudinal regression is found to boost the efficacy of the final model in dealing with both tasks. Different multimodality scenarios are investigated, and complementary aspects of the multimodal features are exploited to simultaneously delineate the subject's label and predict related cognitive scores at future timepoints using baseline data. The main intent in this multitask framework is to consolidate the highest accuracy possible in terms of precision, sensitivity, F1 score, and area under the curve (AUC) in the multiclass classification task while maintaining the highest similarity in the MMSE score as measured through the correlation coefficient and the RMSE for all time points under the prediction task, with both tasks, run simultaneously under the same set of hyperparameters. The overall accuracy for multiclass classification of the proposed KTMnet method is 66.85 ± 3.77. The prediction results show an average RMSE of 2.32 ± 0.52 and a correlation of 0.71 ± 5.98 for predicting MMSE throughout the time points. These results are compared to state-of-the-art techniques reported in the literature. A discovery from the multitasking of this consolidated machine learning framework is that a set of hyperparameters that optimize the prediction results may not necessarily be the same as those that would optimize the multiclass classification. In other words, there is a breakpoint beyond which enhancing further the results of one process could lead to the downgrading in accuracy for the other.

Indexed as

Alzheimer’s diseaselongitudinal regressionmultitask learningneural networkpredictionprogression

Identifiers

PMID35601611
PMCPMC9120529
OpenAlexW4229022637

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.